A Discovery Partner Built for What Comes Next
Whether you’re navigating early discovery or preparing for candidate nomination, X-Chem brings clarity to complex decisions.
Chemomics transforms DEL data into a true discovery advantage, so you can act sooner, reduce risk and move with purpose.
A Discovery Partner Built for What Comes Next
Whether you’re navigating early discovery or preparing for candidate nomination, X-Chem brings clarity to complex decisions.
Chemomics transforms DEL data into a true discovery advantage, so you can act sooner, reduce risk and move with purpose.
Built for Better Decisions
Chemomics turns DEL output into direction; shaping smarter synthesis, faster prioritization and fewer dead ends. It gives your team clarity before the first compound is made, helping you avoid wasted cycles and move forward with higher confidence.
Discovery That Meets You Where You Are
Start with hit finding, lead optimization or candidate nomination. Our modular and milestone-driven programs are built to scale with your goals and reduce risk at every step.
HitBuilder, LeadBuilder, and CandidateBuilder are structured to deliver clarity and momentum. Each program includes built-in decision points, tailored success criteria, and flexibility to shift as priorities evolve.
We operate as an extension of your team, with aligned incentives and full transparency. If a stage doesn’t deliver, you can pause, pivot or reallocate resources without losing time or budget.
X-Chem also provides targeted services between stages, allowing you to engage at the level your project requires.
The X-Chem Difference
A Better Beginning for Every Program
Timelines are shrinking. Targets are tougher. The cost of delays keeps rising.
X-Chem delivers clarity, capability, and results when it matters most.
Why Top Biotech & Pharma Choose X-Chem:
Let’s Build What’s Next
Drug discovery doesn’t pause. Neither should progress. Whether you’re tackling a novel target or advancing a lead, our team is ready to help you move forward.
By Zhen Chen, Senior Principal Scientist Solving the biggest challenge in RNA-targeted DEL screens with a mirror-image approach. RNA-targeted [...]
By Matt Clark, Chief Scientific Officer One of the best parts of being part of X-Chem is seeing all [...]
By Ali Chou, Research Scientist When it comes to drug discovery and development, having the right team and partners [...]
